FASgen
This article was originally published in Start Up
Executive Summary
The serendipitous discovery of fatty acid synthetase (FAS) in tumor biopsies led a team of Johns Hopkins University researchers to start studying the role of FAS in cancer. Some 15 years after this discovery, the researchers founded FASgen Inc. to develop small molecule FAS inhibitors for cancer, obesity, and tuberculosis.